Analysts: J&J doesn't need to worry about Sun Pharma's prostate cancer drug

Sun Pharma surprised the pharma industry when its prostate cancer treatment Yonsa was approved, putting the drug, which treats metastatic-castration-resistant prostate cancer, into direct competition with Johnson & Johnson's Zytiga.